Interferon-Free Regimens in the Liver-Transplant Setting

被引：34

作者：

Lens, Sabela ^{[1
,2
]}

Gambato, Martina ^{[1
,2
]}

Londono, Maria-Carlota ^{[1
,2
]}

Forns, Xavier ^{[1
,2
]}

机构：

[1] IDIBAPS, Hosp Clin, Liver Unit, Barcelona, Spain

[2] CIBEREHD, Barcelona, Spain

来源：

SEMINARS IN LIVER DISEASE | 2014年 / 34卷 / 01期

关键词：

sustained virological response; liver transplantation; adverse events; direct-acting antivirals cirrhosis; HEPATITIS-C-VIRUS; SOFOSBUVIR PLUS RIBAVIRIN; HCV-INFECTED PATIENTS; SUSTAINED VIROLOGICAL RESPONSE; SINGLE-DOSE PHARMACOKINETICS; INHIBITOR-TRIPLE THERAPY; ANTIVIRAL THERAPY; GENOTYPE; INTRAVENOUS SILIBININ; FIBROSIS PROGRESSION;

D O I：

10.1055/s-0034-1371011

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

During 2014 and 2015, different interferon- (IFN-) free regimens will be approved for use in chronic hepatitis C (HCV). The liver-transplantation (LT) setting is the field of hepatology where these regimens will have the highest and fastest impact. Indeed, one study using direct-acting antivirals has already proven the concept that graft HCV infection can be prevented by treating patients awaiting LT. Safety and efficacy of several IFN-free regimens are currently being assessed in patients with hepatitis C recurrence after LT, with good preliminary results. Nevertheless, there are some issues that need to be addressed in the peri-LT setting and are reviewed in this article: (1) efficacy of IFN-free regimens in patients with advanced cirrhosis and portal hypertension, (2) pharmacokinetics of new antivirals in patients with several grades of hepatic or renal impairment, (3) impact of the selection of drug-resistant HCV strains in patients with decompensated cirrhosis or with severe hepatitis C recurrence after LT, and (4) drug-drug interactions.

引用

页码：58 / 71

页数：14

共 103 条

[51] Effect of Telaprevir on the Pharmacokinetics of Cyclosporine and Tacrolimus [J].

Garg, Varun ;

van Heeswijk, Rolf ;

Lee, Jee Eun ;

Alves, Katia ;

Nadkarni, Priya ;

Luo, Xia .

HEPATOLOGY, 2011, 54 (01) :20-27

[52]

Garimella T, 2013, HEPATOLOGY, V58, p430A

[53]

German P, 2013, HEPATOLOGY, V58, p432A

[54] Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC)-NCT01514890 [J].

Hezode, Christophe ;

Fontaine, Helene ;

Dorival, Celine ;

Larrey, Dominique ;

Zoulim, Fabien ;

Canva, Valerie ;

de Ledinghen, Victor ;

Poynard, Thierry ;

Samuel, Didier ;

Bourliere, Marc ;

Zarski, Jean-Pierre ;

Raabe, Jean-Jacques ;

Alric, Laurent ;

Marcellin, Patrick ;

Riachi, Ghassan ;

Bernard, Pierre-Henri ;

Loustaud-Ratti, Veronique ;

Metivier, Sophie ;

Tran, Albert ;

Serfaty, Lawrence ;

Abergel, Armand ;

Causse, Xavier ;

Di Martino, Vincent ;

Guyader, Dominique ;

Lucidarme, Damien ;

Grando-Lemaire, Veronique ;

Hillon, Patrick ;

Feray, Cyrille ;

Thong Dao ;

Cacoub, Patrice ;

Rosa, Isabelle ;

Attali, Pierre ;

Petrov-Sanchez, Ventzislava ;

Barthe, Yoann ;

Pawlotsky, Jean-Michel ;

Pol, Stanislas ;

Carrat, Fabrice ;

Bronowicki, Jean-Pierre .

JOURNAL OF HEPATOLOGY, 2013, 59 (03) :434-441

[55]

Huang FL, 2013, HEPATOLOGY, V58, p431A

[56] Pharmacokinetic Interaction Between the Hepatitis C Virus Protease Inhibitor Boceprevir and Cyclosporine and Tacrolimus in Healthy Volunteers [J].

Hulskotte, Ellen ;

Gupta, Samir ;

Xuan, Fengjuan ;

van Zutven, Marga ;

O'Mara, Edward ;

Feng, Hwa-Ping ;

Wagner, John ;

Butterton, Joan .

HEPATOLOGY, 2012, 56 (05) :1622-1630

[57] Peginterferon alfa-2b and ribavirin in patients with hepatitis C virus and decompensated cirrhosis: A controlled study [J].

Iacobellis, Angelo ;

Siciliano, Massimo ;

Perri, Francesco ;

Annicchiarico, Brigida E. ;

Leandro, Gioacchino ;

Caruso, Nazario ;

Accadia, Laura ;

Bombardieri, Giuseppe ;

Andriulli, Angelo .

JOURNAL OF HEPATOLOGY, 2007, 46 (02) :206-212

[58] TREATMENT WITH SOFOSBUVIR plus RIBAVIRIN FOR 12 WEEKS ACHIEVES SVR12 OF 78% IN GT2/3 INTERFERON-INELIGIBLE, -INTOLERANT, OR -UNWILLING PATIENTS: RESULTS OF THE PHASE 3 POSITRON TRIAL [J].

Jacobson, I. ;

Yoshida, E. M. ;

Sulkowski, M. ;

Nelson, D. R. ;

Svarovskaia, E. ;

An, D. ;

McNally, J. ;

Brainard, D. M. ;

Symonds, W. T. ;

McHutchison, J. G. ;

Pianko, S. ;

Kowdley, K. V. .

JOURNAL OF HEPATOLOGY, 2013, 58 :S28-S28

[59]

Jacobson I, 2013, 64 ANN M AM ASS STUD

[60] Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options [J].

Jacobson, Ira M. ;

Gordon, Stuart C. ;

Kowdley, Kris V. ;

Yoshida, Eric M. ;

Rodriguez-Torres, Maribel ;

Sulkowski, Mark S. ;

Shiffman, Mitchell L. ;

Lawitz, Eric ;

Everson, Gregory ;

Bennett, Michael ;

Schiff, Eugene ;

Al-Assi, M. Tarek ;

Subramanian, G. Mani ;

An, Di ;

Lin, Ming ;

McNally, John ;

Brainard, Diana ;

Symonds, William T. ;

McHutchison, John G. ;

Patel, Keyur ;

Feld, Jordan ;

Pianko, Stephen ;

Nelson, David R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (20) :1867-1877

← 1 2 3 4 5 6 7 8 9 10 →